Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Bone Neoplasms × Etoricoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Bone Neoplasms 1

Interventions

Ibandronic Acid 8 Zoledronic Acid 3 Irinotecan 3 Temozolomide 2 Radiation 2 Doxorubicin 2 Denosumab 2 Cyclophosphamide 2 Cryotherapy 2 Cryosurgery 2 selinexor 1 robatumumab 1 ridaforolimus 1 radium Ra 223 dichloride 1 pegfilgrastim 1 palbociclib 1 liposomal doxorubicin 1 cc-486 1 anlotinib 1 Vincristine 1 Topotecan 1 Taxes 1 Radiotherapy 1 Pregabalin 1 Paclitaxel 1 Observation 1 Lomustine 1 Kyphoplasty 1 Injections 1 Ifosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00095017 2022-02-16

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Organon and Co

Phase 2 Withdrawn

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡